Evolution of the Average Target: Exelon Corporation

Evolution of the Target Price: Exelon Corporation

Changes in Analyst Recommendations: Exelon Corporation

f5bbe10e958c00ef0ba6be.1f5oxWUt5AzRlj_8lyqkwtf85zJD_sRxGn5q7TLgXmY.gJIsv1duoV2T4HGP7Wzwp5q-1ncsjI8zbTZe3WiyFAuhvw2yAUWWdJ7Ceg~385b3962d3e41d2c0c078f47194a05ab
08-21 Morgan Stanley Adjusts Price Target on Exelon to $53 From $55, Keeps Equalweight Rating MT
08-19 JPMorgan Adjusts Exelon Price Target to $47 From $50 MT
07-31 BMO Capital Adjusts Price Target on Exelon to $47 From $48, Maintains Market Perform Rating MT
07-30 The Fed Gets a Better Inflation Number Zonebourse
07-29 Jefferies Adjusts Price Target on Exelon to $49 From $50, Maintains Hold Rating MT
07-22 Morgan Stanley Adjusts Price Target on Exelon to $55 From $54, Maintains Equalweight Rating MT
06-24 Morgan Stanley Adjusts Price Target on Exelon to $54 From $52, Maintains Equalweight Rating MT
05-21 Morgan Stanley Adjusts Price Target on Exelon to $52 From $55, Maintains Equalweight Rating MT
05-15 JPMorgan Adjusts Price Target on Exelon to $49 From $53, Maintains Neutral Rating MT
05-15 TD Cowen Adjusts Price Target on Exelon to $49 From $51, Maintains Hold Rating MT
05-13 KeyBanc Adjusts Price Target on Exelon to $41 From $43, Maintains Underweight Rating MT
05-11 Evercore ISI Adjusts Price Target on Exelon to $57 From $58 MT
04-28 Morgan Stanley Adjusts Price Target on Exelon to $55 From $56, Maintains Equalweight Rating MT
04-22 BMO Capital Adjusts Exelon Price Target to $48 From $49, Maintains Market Perform Rating MT
04-21 Morgan Stanley Adjusts Price Target on Exelon to $55 From $56, Maintains Equalweight Rating MT
04-21 KeyBanc Adjusts Price Target on Exelon to $43 From $44, Maintains Underweight Rating MT
04-20 Exelon Seen Offsetting PECO Rate Case Withdrawal Impact Over Time, RBC Says MT
04-20 Wells Fargo Adjusts Price Target on Exelon to $50 From $53, Maintains Overweight Rating MT
04-20 RBC Lowers Price Target on Exelon to $48 From $51, Keeps Sector Perform Rating MT
04-20 Jefferies Downgrades Exelon to Hold From Buy, Adjusts Price Target to $50 From $55 MT
04-17 Exelon Shares Fall After Multiple Downgrades MT
04-17 Mizuho Downgrades Exelon to Neutral From Outperform, Adjusts Price Target to $48 From $51 MT
04-17 Barclays Downgrades Exelon to Equalweight From Overweight, Adjusts PT to $49 From $50 MT
04-17 BMO Capital Downgrades Exelon to Market Perform From Outperform, Adjusts PT to $49 From $52 MT
04-17 Analyst recommendations: Albemarle, Newmont Corp, Texas Instruments, The Clorox Company, Oxy… Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+11.53%
+37.61%
+18.64%
+3.13%
+11.13%
+13.85%
+24.26%
+14.03%
+17.11%
+8.19%
Average +15.95%
Weighted average by Cap. +18.66%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
43.97USD
Average target price
48.88USD
Spread / Average Target
+11.17%
High Price Target
58.00USD
Spread / Highest target
+31.91%
Low Price Target
41.00USD
Spread / Lowest Target
-6.75%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. EXC Stock
  4. Consensus Exelon Corporation